Comment prendre rendez-vous avec Dr Eric Toussirot ?

Par téléphone au 03 81 66 81 66 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.

D'où viennent les informations de cette page ?

Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.

Dr Eric ToussirotRhumatologue à Besançon

Q: Où consulte Dr Eric Toussirot ?

Dr Eric Toussirot consulte à CHU JEAN MINJOZ BESANCON, 3 Boulevard FLEMING, 25030 Besançon. Adresses issues de l'Annuaire Santé (ANS).

Praticien hospitalier

Appeler· 03 81 66 81 66 Rechercher sur Doctolib

Photo : Wikipedro, CC BY-SA 4.0, Wikimedia Commons

Vous êtes Dr Eric Toussirot ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.

Configurer votre fiche gratuitement →

Dr Eric Toussirot est rhumatologue à Besançon (25030). Il consulte à CHU JEAN MINJOZ BESANCON, 3 Boulevard FLEMING, 25030 Besançon.

Enregistrer le contact

publications: 47publications
citations: 9 047citations

Consulter

Lieu de consultation

CHU JEAN MINJOZ BESANCON
3 Boulevard FLEMING, 25030 Besançon
Hospitalier

Dr Eric Toussirot, c'est vous ?

Faites de cette fiche la page de votre cabinet.

Votre présentationQuelques lignes sur votre pratique, affichées en tête de page.
Vos domaines d'expertiseLes pathologies que vous suivez, à la place des domaines déduits.
Vos actesÉchographie, infiltrations, viscosupplémentation, PRP, téléexpertise.
Vos liensSite du cabinet, LinkedIn, secteur de conventionnement corrigé.

Configurer votre fiche gratuitementGratuit · réservé au praticien

Formation

Parcours et diplômes (11)

DES

DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées

CES

DE Docteur en médecine · Immunologie et Immunopathologie · Immunologie et Immunopathologie (DNQ) — Capacité / certificat d'études spéciales

2013–2026
Inserm
2018–2022
Université de Bourgogne
2021
Centre National de la Recherche Scientifique
2021
Université de Bordeaux
2021
Centre Hospitalier Universitaire de Bordeaux
2016
Centre Hospitalier Universitaire de Grenoble
Affiliations déclarées dans les publications (OpenAlex).

Spondyloarthrite · 12

2026EULAR rheumatology openPubMed

Spondyloarthritis and inflammatory bowel disease: towards a more severe and refractory disease phenotype

2024Expert opinion on biological therapyPubMed

IL-17 inhibitors in axial spondyloarthritis. An overview

2023Drugs & agingPubMed

Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older Patients

2023Expert opinion on pharmacotherapyPubMed

Advances in pharmacotherapies for axial spondyloarthritis

2022Arthritis & rheumatology (Hoboken, N.J.)PubMed

Characterization of mucosal-associated invariant T cells in blood of patients with axial spondyloarthritis and in axial entheses of healthy controls: comment on the article by Rosine et al

2022Pharmaceuticals (Basel, Switzerland)PubMed

The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights

2021Frontiers in medicinePubMed

The Risk of Cardiovascular Diseases in Axial Spondyloarthritis. Current Insights

2021Clinical and experimental rheumatologyPubMed

Sustained remission of ankylosing spondylitis following intravesical Bacillus Calmette et Guérin immunotherapy for bladder cancer

2020Kidney international reportsPubMed

Spondyloarthritis-Associated IgA Nephropathy

2019Expert opinion on pharmacotherapyPubMed

Pharmacological management of axial spondyloarthritis in adults

2018RMD openPubMed

MAIT cells: potent major cellular players in the IL-17 pathway of spondyloarthritis?

2018The Journal of rheumatologyPubMed

Unilateral Accessory Sacroiliac Joint with Bone Marrow Edema Mimicking Sacroiliitis

Polyarthrite rhumatoïde · 8

2025Frontiers in immunologyPubMed

Citrullinated peptides of peptidyl arginine deiminase 4 as major B-cell epitopes in patients with rheumatoid arthritis

2022Joint bone spinePubMed

Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma

2021RMD openPubMed

Lymphoma complicating rheumatoid arthritis: results from a French case-control study

2021Frontiers in immunologyPubMed

Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives

Transversal · 8

2026Journal of Parkinson's diseasePubMed

Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment

2025EULAR rheumatology openPubMed

Occurrence of amyotrophic lateral sclerosis during TNF inhibitor treatment in inflammatory rheumatic disease. What are the relationships?

2024Frontiers in medicinePubMed

Areal bone mineral density, trabecular bone score and 3D-DXA analysis of proximal femur in psoriatic disease

2023Frontiers in medicinePubMed

Editorial: Impact and consequences of COVID-19 on the musculoskeletal system

Biothérapies non-anti-TNF · 6

2025Arthritis & rheumatology (Hoboken, N.J.)PubMed

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica

2022JAMAPubMed

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial

2021The Journal of rheumatologyPubMed

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica

2020Seminars in arthritis and rheumatismPubMed

Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series

Polymyalgia rheumatica · 5

2025Arthritis & rheumatology (Hoboken, N.J.)PubMed

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica

2024RMD openPubMed

Concordance and agreement between different activity scores in polymyalgia rheumatica

2022JAMAPubMed

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial

2021The Journal of rheumatologyPubMed

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica

Biomarqueurs / Auto-Ac · 3

2025Frontiers in immunologyPubMed

Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume III

2024Frontiers in immunologyPubMed

Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II

2021Frontiers in immunologyPubMed

Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases

Anti-IL-17 · 2

2024Expert opinion on biological therapyPubMed

IL-17 inhibitors in axial spondyloarthritis. An overview

2018RMD openPubMed

MAIT cells: potent major cellular players in the IL-17 pathway of spondyloarthritis?

Essai clinique · 2

2025EBioMedicinePubMed

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial

2023BMJ openPubMed

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial

Revue générale · 2

2025Frontiers in medicinePubMed

Bone health in Parkinson's disease: a comprehensive review of bone involvement and its pathophysiological mechanisms

2020Frontiers in endocrinologyPubMed

Mini-Review: The Contribution of Adipokines to Joint Inflammation in Inflammatory Rheumatic Diseases

Risque cardio-vasculaire · 2

2021Frontiers in medicinePubMed

The Risk of Cardiovascular Diseases in Axial Spondyloarthritis. Current Insights

2021Rheumatology (Oxford, England)PubMed

Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk

Anti-TNF · 1

2019Clinical and experimental rheumatologyPubMed

Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis

Arthrite juvénile · 1

2023Frontiers in immunologyPubMed

ATHLETIQUE: interest of an adapted physical activity program in patients with juvenile idiopathic arthritis: a feasibility and preliminary effectiveness study

csDMARDs · 1

2020Clinics and research in hepatology and gastroenterologyPubMed

A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy

Épidémiologie & registres · 1

2026Clinical and experimental dermatologyPubMed

Biologics in patients with immune-mediated inflammatory diseases and malignancies: a study derived from two registries

JAK inhibiteurs · 1

2024Rheumatology (Oxford, England)PubMed

Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry

Ostéoporose · 1

2026Expert opinion on pharmacotherapyPubMed

Therapeutic management of osteoporosis in Parkinson's disease

Rhumatisme psoriasique · 1

2021Rheumatology (Oxford, England)PubMed

Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk

Sarcoïdose · 1

2019Clinical and experimental rheumatologyPubMed

Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis

Vascularites · 1

2018Autoimmunity reviewsPubMed

Anti-neutrophil cytoplasmic antibody-associated chronic inflammatory arthritis without vasculitis. Data from a French nationwide survey

Dr Eric ToussirotRhumatologue à Besançon

Lieu de consultation

Préparer votre rendez-vous

Conventionnement et remboursement

Expertise et points clés

Parcours et diplômes (11)

Travaux scientifiques (57)

Questions fréquentes sur Dr Eric Toussirot

Où consulte Dr Eric Toussirot ?

Comment prendre rendez-vous avec Dr Eric Toussirot ?

D'où viennent les informations de cette page ?

Rhumatologues à Besançon et alentours